Vahav, I.; Thon, M.; van den Broek, L.J.; Spiekstra, S.W.; Atac, B.; Lindner, G.; Schimek, K.; Marx, U.; Gibbs, S.
Proof-of-Concept Organ-on-Chip Study: Topical Cinnamaldehyde Exposure of Reconstructed Human Skin with Integrated Neopapillae Cultured under Dynamic Flow. Pharmaceutics 2022, 14, 1529.
https://doi.org/10.3390/pharmaceutics14081529
AMA Style
Vahav I, Thon M, van den Broek LJ, Spiekstra SW, Atac B, Lindner G, Schimek K, Marx U, Gibbs S.
Proof-of-Concept Organ-on-Chip Study: Topical Cinnamaldehyde Exposure of Reconstructed Human Skin with Integrated Neopapillae Cultured under Dynamic Flow. Pharmaceutics. 2022; 14(8):1529.
https://doi.org/10.3390/pharmaceutics14081529
Chicago/Turabian Style
Vahav, Irit, Maria Thon, Lenie J. van den Broek, Sander W. Spiekstra, Beren Atac, Gerd Lindner, Katharina Schimek, Uwe Marx, and Susan Gibbs.
2022. "Proof-of-Concept Organ-on-Chip Study: Topical Cinnamaldehyde Exposure of Reconstructed Human Skin with Integrated Neopapillae Cultured under Dynamic Flow" Pharmaceutics 14, no. 8: 1529.
https://doi.org/10.3390/pharmaceutics14081529
APA Style
Vahav, I., Thon, M., van den Broek, L. J., Spiekstra, S. W., Atac, B., Lindner, G., Schimek, K., Marx, U., & Gibbs, S.
(2022). Proof-of-Concept Organ-on-Chip Study: Topical Cinnamaldehyde Exposure of Reconstructed Human Skin with Integrated Neopapillae Cultured under Dynamic Flow. Pharmaceutics, 14(8), 1529.
https://doi.org/10.3390/pharmaceutics14081529